David Hirsch
Director/Board Member bij RAPID MICRO BIOSYSTEMS, INC.
Vermogen: - $ op 31-03-2024
Profiel
David J.
Hirsch is the founder.
He founded Longitude Capital Management Co LLC in 2006, where he holds the title of Venture Partner & Managing Director.
Currently, Dr. Hirsch is the Chief Executive Officer & Director at Alpha-9 Oncology, Inc. since 2022 and the Independent Director at Rapid Micro Biosystems, Inc. since 2013.
Previously, he served as the Director at Collegium Pharmaceutical, Inc. from 2012 to 2020, Independent Director at Tricida, Inc. from 2016 to 2023, Director at Helomics Corp., Director at Predictive Oncology, Inc. from 2009 to 2013, Director at Civitas Therapeutics, Inc. from 2011 to 2014, Director at Velicept Therapeutics, Inc. from 2015 to 2020, Independent Director at Poseida Therapeutics, Inc. from 2018 to 2022, Director at Zavante Therapeutics, Inc. from 2015 to 2018, Director at Inflazome Ltd.
from 2018 to 2020, Director at Amunix Pharmaceuticals, Inc. from 2020 to 2022, and Independent Director at Molecular Templates, Inc. from 2017 to 2023.
Dr. Hirsch also held the position of Vice President at Pequot Capital Management, Inc. from 2005 to 2006 and Vice President at FirstMark Capital LLC from 2005 to 2006.
He started his career as an Engagement Manager at McKinsey & Co., Inc. from 2001 to 2004.
Dr. Hirsch obtained a doctorate degree from Massachusetts Institute of Technology in 2001, an undergraduate degree from The Johns Hopkins University in 2001, and a doctorate degree from Harvard Medical School in 2001.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van David Hirsch
| Bedrijven | Functie | Begin |
|---|---|---|
| RAPID MICRO BIOSYSTEMS, INC. | Director/Board Member | 01-06-2013 |
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Chief Executive Officer | 01-10-2022 |
Longitude Capital Management Co LLC
 Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | Founder | 01-07-2006 |
Eerdere bekende functies van David Hirsch
| Bedrijven | Functie | Einde |
|---|---|---|
| TRICIDA, INC. | Director/Board Member | 01-06-2023 |
| MOLECULAR TEMPLATES, INC. | Director/Board Member | 01-05-2023 |
| POSEIDA THERAPEUTICS, INC. | Director/Board Member | 17-05-2022 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Director/Board Member | 28-02-2022 |
Velicept Therapeutics, Inc.
 Velicept Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Velicept Therapeutics, Inc. manufactures biopharmaceutical products. The firm offers Solabegron, which is used for the treatment of overactive bladder in women and irritable bowel syndrome. The company was founded in 2015 and is headquartered in Wayne, PA. | Director/Board Member | 30-11-2020 |
Opleiding van David Hirsch
| Massachusetts Institute of Technology | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 6 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| RAPID MICRO BIOSYSTEMS, INC. | Producer Manufacturing |
| TRICIDA, INC. | Health Technology |
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Bedrijven in privébezit | 11 |
|---|---|
Pequot Capital Management, Inc.
 Pequot Capital Management, Inc. Investment ManagersFinance Founded in 1998 by Arthur J. Samberg, Pequot Capital Management Inc. is a hedge fund manager headquartered in Wilton, Connecticut with offices in New York City and Los Angeles. They manage the Pequot Family of Funds. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
FirstMark Capital LLC
 FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | Finance |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Health Services |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | Finance |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Velicept Therapeutics, Inc.
Velicept Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Velicept Therapeutics, Inc. manufactures biopharmaceutical products. The firm offers Solabegron, which is used for the treatment of overactive bladder in women and irritable bowel syndrome. The company was founded in 2015 and is headquartered in Wayne, PA. | Health Technology |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | Health Technology |
Inflazome Ltd.
 Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Commercial Services |
